Search

Due to the developing nature of the ongoing COVID-19 pandemic, the effect of other health conditions on COVID-19 outcomes is not yet clear. This study, published in Blood Advances, identified predictors of outcomes and survival in patients with COVID-19 and sickle cell disease.  Data from patients in four COVID-19 epicenters were used. Patients had a median...

In this MD Newsline exclusive interview with endocrinologist/obesity medicine specialist Dr. Rocio Salas-Whalen, we discuss the prevalence of severe obesity in the African American and Hispanic American communities. We also discuss how obesity development and obesity management are impacted by socioeconomic status and COVID-19. MD Newsline: Have you seen a difference in obesity prevalence in...

WEDNESDAY, Sept. 30, 2020 (HealthDay News) — The incidence of COVID-19 was higher in adolescents than among children during May to September 2020, according to research published in the Sept. 28 early-release issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report. Rebecca T. Leeb, Ph.D., from the CDC COVID-19...

Black Americans are more likely to experience chronic insomnia than white Americans. This disparity may result from a lack of appropriate access to care, especially during the pandemic. Moreover, the gap in insomnia prevalence may be widened by additional stress caused by the pandemic as Black Americans also experience higher rates of infection and poorer...

WEDNESDAY, Oct. 7, 2020 (HealthDay News) — Lopinavir-ritonavir is not associated with reductions in 28-day mortality or duration of hospital stay among patients admitted to the hospital with COVID-19, according to a study published online Oct. 5 in The Lancet. Peter W. Horby, M.D., Ph.D., and colleagues on behalf of the RECOVERY Collaborative Group conducted...

The effects of COVID-19 vaccination on people with multiple sclerosis has not been studied in sufficient detail. This study provides an analysis of the available data. COVID-19 infection as well as the various COVID-19 vaccines have caused health complications for some patients with certain medical conditions. Despite the vaccine being available for a number of...

In this MD Newsline exclusive interview with dermatologist Dr. Victoria Barbosa, we discuss disparities in diagnosing and treating central centrifugal cicatricial alopecia (CCCA) before and during the COVID-19 pandemic. MD Newsline: What disparities in diagnosing and treating CCCA have you observed in your clinical practice? Dr. Victoria Barbosa: “Recent research has shown us that CCCA...

In this MD Newsline exclusive interview with Krystal Preston, PharmD, we discuss disparities in treating sickle cell disease before and during the COVID-19 pandemic. MD Newsline: What disparities in treating sickle cell disease have you observed as a clinical pharmacist? Krystal Preston, PharmD: “As a pharmacist as well as a patient living with sickle cell...

WEDNESDAY, Oct. 14, 2020 (HealthDay News) — Enrollment in a study testing an experimental antibody therapy against COVID-19 has been paused by independent monitors. The study, ACTIV-3, was testing the use of a single antibody with the antiviral drug remdesivir. The antibody is being developed by Eli Lilly and the Canadian company AbCellera, the Associated...

FRIDAY, Oct. 9, 2020 (HealthDay News) — For patients hospitalized with COVID-19, remdesivir is superior for shortening time to recovery compared with placebo, according to a study published online Oct. 8 in the New England Journal of Medicine. John H. Beigel, M.D., from the National Institutes of Health in Bethesda, Maryland, and colleagues conducted a...